Alere Inc. (ALR) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Alere Inc. (ALR) - Medical Equipment - Deals and Alliances Profile

Alere Inc. (ALR) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Alere Inc. (ALR) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
98 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Alere Inc. (Alere) is one of the leading providers of point-of-care diagnostics solutions and services with focus on cardiology, womens health, infectious diseases, diabetes, oncology, and toxicology. It offers testing and monitoring products including point-of-care and laboratory tests within the infectious disease, cardiometabolic disease, toxicology and patient self-testing domains. It also offers diabetic testing supplies, including blood glucose monitors, test strips, lancets, lancing devices, and control solutions, and other related medical supplies in the US.

Alere Inc. (ALR) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target

  
Source:
Document ID
GDME361D
Country
Industry
Ticker
ALR=US
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents25
  List of Tables42
  List of Figures61
Alere Inc., Medical Equipment, Deals By Year, 2010 to YTD 201662
Alere Inc., Medical Equipment Deals By Type, 2010 to YTD 201681
Alere Inc., Medical Equipment, Deals By Region, 2010 to YTD 201691
Alere Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016101
Alere Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016113
Alere Inc., Medical Equipment, Deal Details1452
  Private Equity141
    Pharos Capital Group Acquires Majority Stake in TechLab142
    Exponent Private Equity Acquires BBI Diagnostics from Alere for USD162 Million161
  Partnerships171
    Axis-Shield Enters into Licensing Agreement with Hangzhou Joinstar Biomedical171
    Axis-Shield Diagnostic Enters into Licensing Agreement with Siemens Healthcare Diagnostics181
    Alere Exercises Option For Licensing Agreement With Miraculins For Endoglin Products191
    VitaPath Genetics Enters Into Licensing Agreement With Alere201
    Thermo Fisher Scientific Enters Into Licensing Agreement With Alere211
    Alere Enters Into Licensing Agreement With Roche Diagnostics221
    Roche Diagnostics Enters Into Licensing Agreement With Alere231
    Chembio Terminates Distribution Agreement With Alere241
    Alere Enters Into Co-Development Agreement With AT&T251
    EKF Diagnostics Enters Into Distribution Agreement With Alere261
    Spartan Bioscience Enters Into Distribution Agreement With Alere271
    Systagenix Wound Management Enters Into Co-Development Agreement With Alere281
    Laboratorios Rubio Enters Into Distribution Agreement With Alere Healthcare291
    AnaSpec Enters Into Distribution Agreement With Bioeasy Diagnostica301
    BG Medicine Enters Into An Agreement With Inverness Medical Innovations311
    FIND Enters Into Agreement With Standard Diagnostics321
    Miraculins Enters Into An Agreement With Inverness Medical Innovations331
    Inverness Medical Innovations Enters Into Distribution Agreement With Epocal341
    AdnaGen Extends Licensing Agreement With KellBenx351
  Debt Offering361
    Alere Raises USD425 Million in Private Placement of 6.37% Notes Due 2023361
    Alere Completes Private Placement Of Notes Due 2020 For US$425 Million372
    Alere Completes Private Placement Of Notes Due 2018 For US$450 Million392
    Alere Completes Private Placement Of Senior Subordinate Notes For US$400 Million411
  Asset Transactions421
    QIAGEN Acquires Circulating Tumor Cell Technology from AdnaGen421
    Coppersmith Capital Management Reportedly Wants Alere To Explore Sale Of Its Drug Testing And Toxicology Businesses For Up To US$5 Billion431
  Acquisition441
    Abbott Labs to Acquire Alere442
    Alere Acquires US Diagnostics USD60 Million461
    Ron Zwanziger Plans to Acquire Alere for USD3.82 Billion471
    Alere Completes Acquisition Of Epocal For Up To US$241 Million482
    Alere Acquires eScreen for USD296 Million502
    Arriva Medical Acquires AmMed Direct For US$23 Million521
    Arriva Medical Acquires Direct Diabetic Source531
    Alere Completes Acquisition Of Medical Automation System541
    Alere Acquires Arriva Medical From Palm Beach Capital For US$83 Million551
    Alere Completes Acquisition Of Axis-Shield, Diagnostic Test Maker, For US$389 Million562
    Alere Acquires Lab Data Systems581
    Alere Holdings Bermuda Acquires 78% Stake Of AdnaGen From OncoVista Innovative Therapies592
    EKF Diagnostics Acquires Quotient Diagnostics612
    Inverness Medical Innovations Acquires 78.13% Stake In Standard Diagnostics632
    Inverness Medical Innovations To Acquire Kroll Lab Specialists From Kroll651
Alere Inc. - Key Competitors661
Key Employees672
Locations And Subsidiaries697
  Head Office691
  Other Locations &Subsidiaries697
Recent Developments761
Financial Announcements761
Sep 06, 2016: Alere Reports Second Quarter 2016 Financial Results761
Aug 17, 2016: Alere Reports First Quarter 2016 Financial Results771
Aug 08, 2016: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results782
Nov 04, 2015: Alere Reports Third Quarter 2015 Financial Results802
May 05, 2015: Alere Reports Preliminary First Quarter 2015 Financial Results and Announces 2014 Restatement821
Feb 10, 2015: Alere Announces Fourth Quarter 2014 Results832
Corporate Communications851
Jul 23, 2015: Dr. Geoffrey S. Ginsburg Joins Alere Board851
Mar 09, 2015: Alere Announces Chief Financial Officer Transition861
Legal and Regulatory871
Oct 15, 2015: Alere Receives U.S. HHS Approval to Electronically Process Drug Tests for Department of Transportation-Regulated Employees871
Product News881
Mar 18, 2016: Alere Comments on Alere Anticoagulation Monitoring Technology881
Jul 16, 2015: Alere Receives FDA CLIA Waiver for Alere i Strep A Rapid Molecular Test891
Apr 02, 2015: Alere Receives FDA Clearance for Alere i Strep A Rapid Molecular Test901
Mar 02, 2015: Alere Receives IVD CE Mark for Alere q HIV-1/2 Detect Assay for Molecular Diagnosis of HIV at the Point of Care911
Jan 07, 2015: Alere Receives FDA CLIA Waiver for Alere i Influenza A &B Test921
Jan 06, 2015: FDA grants first CLIA waiver for nucleic acid-based flu diagnostic test931
Product Approvals941
Apr 02, 2015: Alere Receives FDA Clearance for Alere i Strep A Rapid Molecular Test941
Mar 02, 2015: Alere Receives IVD CE Mark for Alere q HIV-1/2 Detect Assay for Molecular Diagnosis of HIV at the Point of Care951
Jan 06, 2015: FDA grants first CLIA waiver for nucleic acid-based flu diagnostic test961
Other Significant Developments971
Jun 10, 2015: New Approach on HIV Viral Load Testing971
Appendix981
  Methodology981
  About GlobalData981
  Contact Us981
  Disclaimer981

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Alere Inc. (ALR) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. May 04, 2025. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Alere-Inc-ALR-Medical-Equipment-Deals-and-Alliances-Profile-2148-10374>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Alere Inc. (ALR) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Alere-Inc-ALR-Medical-Equipment-Deals-and-Alliances-Profile-2148-10374>
  
US$ 250.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research